Psychiatry and Neurology, Neurology · Tampa, FL
NPI
1356572119
Since 2009
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4710 N Habana Ave Ste 203
Tampa, FL, 33614
Phone (813) 995-1775
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
1,298 services
Medicare patients, 2024
83
Average age 69
Drug cost, 2024
$698K
2,201 prescriptions
Company payments, 2025
$3,392
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Faizi Ahmed was code 90868 (treatment - miscellaneous), 552 times for 19 patients. In total Faizi Ahmed billed 1,298 services in 14 codes, and Medicare paid $193K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90868 Treatment - Miscellaneous | Office | 552 | 19 | $145.48 | $80K |
| 90833 Psychotherapy - Nongroup | Office | 182 | 78 | $51.56 | $9,384 |
| 99214 Office E&M - Established | Office | 182 | 75 | $91.28 | $17K |
| 90867 Treatment - Miscellaneous | Office | 16 | 15 | $222.42 | $3,559 |
| 90869 Treatment - Miscellaneous | Office | 15 | 14 | $210.35 | $3,155 |
By year: 2022 $113K for 1,402 services; 2023 $113K for 1,198 services; 2024 $193K for 1,298 services.
Medicare prescription drug claims, 2024
In 2024, the drug Faizi Ahmed prescribed most often to Medicare patients was Spravato (Esketamine Hcl), with 420 prescriptions and refills. In total Faizi Ahmed wrote 2,201 Medicare prescriptions that cost $698K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spravato Esketamine Hcl | 420 | 420 | 27 | $524K |
| Alprazolam Generic | 152 | 170 | 42 | $1,307 |
| Clonazepam Generic | 137 | 149 | 45 | $905 |
| Quetiapine Fumarate Generic | 86 | 133 | 20 | $1,672 |
| Lamotrigine Generic | 86 | 157 | 28 | $1,058 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 80 | 92 | 27 | $2,453 |
| Trazodone Hcl Generic | 69 | 123 | 29 | $549 |
| Escitalopram Oxalate Generic | 67 | 129 | 27 | $660 |
| Buspirone Hcl Generic | 59 | 108 | 19 | $815 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 59 | 69 | 13 | $2,674 |
| Mirtazapine Generic | 59 | 128 | 25 | $1,282 |
| Lorazepam Generic | 55 | 92 | 24 | $596 |
| Duloxetine Hcl Generic | 50 | 113 | 21 | $1,140 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 48 | 80 | Under 11 | $951 |
| Fluoxetine Hcl Generic | 46 | 110 | 19 | $450 |
Brand drugs: 557 claims; generic drugs: 1,644 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Faizi Ahmed $3,392 ($3,392 in general payments such as food, travel and fees) from 22 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $471.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $471 |
| Janssen Pharmaceuticals, Inc JNJ | 15 | $389 |
| Neurocrine BioSciences, Inc. NBIX | 13 | $330 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 17 | $323 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 15 | $273 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 14 | $252 |
| Axsome Therapeutics, Inc. AXSM | 9 | $218 |
| Vanda Pharmaceuticals Inc. VNDA | 11 | $217 |
| Alkermes, Inc. ALKS | 4 | $151 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.